Detalhe da pesquisa
1.
Racial disparities in breast cancer hereditary risk assessment referrals.
J Genet Couns
; 29(4): 587-593, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196827
2.
The Perils of Single-Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next-Generation Sequencing.
Oncologist
; 23(4): 393-396, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29445031
3.
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
Nat Commun
; 15(1): 2691, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538574
4.
Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review.
J Cancer Surviv
; 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37093518
5.
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
medRxiv
; 2023 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105958
6.
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121644
7.
Assessing Breast Cancer Survivors' Perceptions of Using Voice-Activated Technology to Address Insomnia: Feasibility Study Featuring Focus Groups and In-Depth Interviews.
JMIR Cancer
; 6(1): e15859, 2020 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348274
8.
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
Clin Breast Cancer
; 20(2): 125-130, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31526714
9.
A Feasibility Study of Group-Delivered Behavioral Interventions for Insomnia Among Breast Cancer Survivors: Comparing Cognitive Behavioral Therapy for Insomnia and a Mind-Body Intervention.
J Altern Complement Med
; 25(8): 840-844, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237434
10.
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
Nat Commun
; 15(1): 3957, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730268
11.
Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
Obstet Gynecol
; 131(6): 1103-1110, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742654
12.
Response to Letter to the Editor: High Oncotype DX Recurrence Score, Hereditary Cancer Syndromes, and Referral for Germline Genetic Testing.
Clin Breast Cancer
; 20(2): e198-e199, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31964593
13.
A Life Potentially Saved Through Hereditary Cancer Panel Testing.
J Oncol Pract
; 13(4): 279-281, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28195815